Reply to: “Baseline Brain Metastasis Imbalance in TRUST: Implications for Interpreting Intracranial Efficacy of Taletrectinib” and “Taletrectinib in ROS1 Fusion–Positive Non–Small Cell Lung Cancer: Promising Yet Premature?”

Maurice Pérol

Wei Li

Rose K. Lai

Maurice Pérol, MD, Department of Medical Oncology, Leon Bérard Cancer Center, Lyon, France, Wei Li, MD, Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China, Rose K. Lai, MD, Nuvation Bio, New York, NY, Caicun Zhou, MD, PhD, Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China, Department of Medical Oncology, East Hospital, Tongji University School of Medicine, Shanghai, China

Caicun Zhou